Equities

Zhejiang Huakang Pharmaceutical Co Ltd

605077:SHH

Zhejiang Huakang Pharmaceutical Co Ltd

Actions
Consumer Staples Food Producers
  • Price (CNY)15.32
  • Today's Change-0.29 / -1.86%
  • Shares traded5.48m
  • 1 Year change-11.21%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2,5891,411361
Total Receivables, Net530402270
Total Inventory282279200
Prepaid expenses122919
Other current assets, total1.2117953
Total current assets3,4152,1381,803
Property, plant & equipment, net2,0141,3591,007
Goodwill, net3462626
Intangibles, net28324290
Long term investments9412359
Note receivable - long term------
Other long term assets------
Total assets6,1783,9053,004
LIABILITIES
Accounts payable312302217
Accrued expenses584642
Notes payable/short-term debt303313131
Current portion long-term debt/capital leases172410.81
Other current liabilities, total1776865
Total current liabilities1,022770456
Total long term debt1,86834621
Total debt2,344700153
Deferred income tax927454
Minority interest12----
Other liabilities, total945938
Total liabilities3,0881,249570
SHAREHOLDERS EQUITY
Common stock235228163
Additional paid-in capital1,4791,4051,470
Retained earnings (accumulated deficit)1,2571,023801
Treasury stock - common(77)----
Unrealized gain (loss)------
Other equity, total196(0.01)(0.02)
Total equity3,0892,6562,434
Total liabilities & shareholders' equity6,1783,9053,004
Total common shares outstanding297297297
Treasury shares - common primary issue8.0000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.